跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,652 条关于
“complement protein C5”
全部
13,652
临床试验
5,941
药物
1,292
机构
55
资讯
6,364
去年
Astellas Withdraws European Application for Avacincaptad Pegol in Geographic Atrophy
去年
Astellas Seeks First Japanese Approval for Geographic Atrophy Treatment with Avacincaptad Pegol
去年
Newcastle Study Shows Safe Withdrawal of Eculizumab in Rare Kidney Disease, Saving NHS £4.2 Million Per Patient
8个月前
AstraZeneca Advances Weight-Loss Drug Elecoglipron to Phase III as Company Targets $80B Revenue by 2030
昨天
CHMP Backs AstraZeneca's Klygefa (gefurulimab) for Generalised Myasthenia Gravis in the EU
去年
Breakthrough Treatments Transform Landscape for Rare Hemolytic Anemias: From C5 Inhibitors to Novel Therapeutic Approaches
2年前
FDA Approves Fabhalta (Iptacopan) as First Oral Monotherapy for PNH
去年
ImmunAbs Receives FDA Clearance for Phase 2 Trial of IM-101 Complement Inhibitor in Myasthenia Gravis
3年前
Iptacopan Shows Promise in Complement-Inhibitor-Naïve PNH Patients
去年
Complement Inhibitors Show Promise in Diverse Clinical Trials
第 1 页,共 637 页
上一页
下一页